Related Experiment Video
Updated: May 24, 2025

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Electronic Cigarette Use Among Adults in the United States, 2019-2023
Introduction:
This report uses data from the 2019-2023 National Health Interview Survey (NHIS) to present 5-year trends in electronic cigarette use among adults and to show how prevalence estimates changed between 2019 and 2023 for men and women and by age and race and ethnicity.
Methods:
Point estimates and the corresponding confidence intervals for this analysis were calculated using SAS-callable SUDAAN software to account for the complex sample design of NHIS. Differences between percentages were evaluated using two-sided significance tests at the 0.05 level. Linear and quadratic trends by year and age were evaluated using orthogonal polynomials.
Key Findings:
The percentage of adults who used electronic cigarettes increased from 4.5% in 2019 to 6.5% in 2023. In both 2019 and 2023, men were more likely than women to use electronic cigarettes. In 2023, young adults ages 21-24 were most likely to use electronic cigarettes (15.5%). The percentage of adults who used electronic cigarettes varied by race and Hispanic ethnicity in both 2019 and 2023.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Statistical Methods for Analyzing Epidemiological Data
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Inhaled Medications
Chronic Obstructive Pulmonary Disease-I: Introduction
Methods of Documentation VII: EMR